Biological
Ended Awarded Last action
- Contract number
- 75N91023F00009
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,324
Award facts
- Contract value 100% obligated
- $24,324.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a BPA call to 10X Genomics, Inc. valued at $24,324.00, awarded July 21, 2023, with final completion on December 26, 2023. The call covers biological supplies and instruments, performed at 10X Genomics' facility in Pleasanton, California. No set-aside was applied.
Quick answers
Who was awarded contract 75N91023F00009?
75N91023F00009 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on July 21, 2023.
How much is contract 75N91023F00009 worth?
The government has obligated $24,324 on 75N91023F00009.
Is contract 75N91023F00009 an order under another contract?
Yes. 75N91023F00009 is a BPA call under 75N98022A00032, a blanket purchase agreement.
Was contract 75N91023F00009 competed?
The extent of competition for 75N91023F00009 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award